https://www.selleckchem.com/products/lly-283.html
tor G2 showed high blood-feeding inhibition against all strains. Both free-flying laboratory bioassays (WHO Tunnel and I-ACT) consistently measured similarly, and both predicted the results of the experimental hut test. For bioefficacy monitoring and upstream product evaluation of ITNs in situ, the I-ACT may provide an alternative bioassay modality with improved statistical power. Interceptor G2 outperformed Interceptor against pyrethroid-resistant strains, demonstrating the usefulness of chlorfenapyr in mitigation of malaria. Both free
إعجاب
علق
شارك
